Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Raymond

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Novel molecular therapies in hepatocellular carcinomaSandrine Faivre, Mohamed Bouattour, Eric Raymond
Therapeutics and Clinical Risk Management|March 25, 2008
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)Christophe Le Tourneau, Eric Raymond, Sandrine Faivre
Oncoimmunology|February 16, 2017
Novel TGF-<b>β</b> inhibitors ready for prime time in onco-immunologyArmand de Gramont, Sandrine Faivre, Eric Raymond
Oncology (Williston Park, N.Y.)|October 12, 2007
The role of integrins in colorectal cancerChristophe Le Tourneau, Sandrine Faivre, Eric Raymond
Targeted Oncology|May 24, 2020
Impact of the COVID-19 Outbreak on the Management of Patients with CancerEric Raymond, Catherine Thieblemont, Severine Alran, et al.
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Molecular Cancer Therapeutics|July 11, 2007
Lessons learned in the development of targeted therapy for malignant gliomasAntonio M P Omuro, Sandrine Faivre, Eric Raymond
Therapeutic Advances in Medical Oncology|January 10, 2012
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialCatherine Delbaldo, Sandrine Faivre, Chantal Dreyer, et al.
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Cells|July 14, 2023
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint InhibitorsEloïne Bestion, Eric Raymond, Soraya Mezouar, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Novel molecular therapies in hepatocellular carcinomaSandrine Faivre, Mohamed Bouattour, Eric Raymond
Therapeutics and Clinical Risk Management|March 25, 2008
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)Christophe Le Tourneau, Eric Raymond, Sandrine Faivre
Oncoimmunology|February 16, 2017
Novel TGF-<b>β</b> inhibitors ready for prime time in onco-immunologyArmand de Gramont, Sandrine Faivre, Eric Raymond
Oncology (Williston Park, N.Y.)|October 12, 2007
The role of integrins in colorectal cancerChristophe Le Tourneau, Sandrine Faivre, Eric Raymond
Targeted Oncology|May 24, 2020
Impact of the COVID-19 Outbreak on the Management of Patients with CancerEric Raymond, Catherine Thieblemont, Severine Alran, et al.
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Molecular Cancer Therapeutics|July 11, 2007
Lessons learned in the development of targeted therapy for malignant gliomasAntonio M P Omuro, Sandrine Faivre, Eric Raymond
Therapeutic Advances in Medical Oncology|January 10, 2012
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialCatherine Delbaldo, Sandrine Faivre, Chantal Dreyer, et al.
Targeted Oncology|November 14, 2009
Sunitinib paves the way for targeted therapies in neuroendocrine tumorsEric Raymond, Sandrine Faivre, Pascal Hammel, et al.
Cells|July 14, 2023
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint InhibitorsEloïne Bestion, Eric Raymond, Soraya Mezouar, et al.
Pageof 18